COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    NCT02258217
Previous Study | Return to List | Next Study

Tolerability of Acthar for the Treatment of Multiple Sclerosis in Relapses (TAMS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02258217
Recruitment Status : Completed
First Posted : October 7, 2014
Last Update Posted : September 12, 2017
Information provided by (Responsible Party):
Aaron Boster, Riverside Methodist Hospital

Results Submitted - Not Posted on
Results information has been submitted to by the sponsor or investigator, but is not yet publicly available (or "posted") on The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : June 24, 2016
Actual Study Completion Date : December 2016
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 January 10, 2019
January 28, 2019
2 May 22, 2019
June 11, 2019